Sign in to view content

Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial

Diana V Do, MD, FASRS

Video
Published 2023

Related

Complications, Compliance, and 2-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for PDR-Related Vitreous Hemorrhage
Dennis M. Marcus, MD
Annual Meeting Talks
2020
Aflibercept 8 mg in Diabetic Macular Edema: 156-Week Results From the PHOTON Extension Study
Eric W Schneider, MD
Updates from the Field
2025
Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes
Jeffrey G. Gross, MD, FASRS
Updates from the Field
2018

Category: Diabetic Retinopathy

See more